Aortic calcification: Novel insights from familial hypercholesterolemia and potential role for the low-density...

Area of Science:

• Cardiovascular Biology
• Vascular Biology
• Biomedical Research

Background:

• Vascular calcification, previously passive, is now understood as a regulated process involving osteoblast-like cells and various signaling pathways.
• This condition significantly contributes to cardiovascular morbidity and mortality due to a lack of effective interventions.
• Familial hypercholesterolemia (FH) patients exhibit severe, premature aortic calcification.

Purpose of the Study:

• To investigate the role of the low-density lipoprotein receptor (LDL-R) in vascular calcification.
• To explore the potential of LDL-R as a therapeutic target for preventing or reversing vascular calcification.

Main Methods:

• Analysis of aortic calcification in human subjects with FH, correlating with LDL-R gene dosage.
• Examination of LDL-R deficient mice and transgenic mice overexpressing PCSK9 for aortic calcification.
• Investigating the molecular mechanisms underlying LDL-R's role in vascular calcification.

Main Results:

• A gene-dosage effect of LDL-R deletion was observed on aortic calcification in FH patients.
• LDL-R deficient and PCSK9-overexpressing mice showed aortic calcification, independent of elevated LDL cholesterol.
• These findings suggest a novel inhibitory role for LDL-R in vascular calcification.

Conclusions:

• The low-density lipoprotein receptor (LDL-R) plays a significant role in inhibiting vascular calcification.
• Understanding LDL-R's molecular interactions is crucial for developing new therapies for vascular calcification.
• Targeting LDL-R signaling pathways could offer novel therapeutic strategies for this prevalent cardiovascular condition.